Dede Fatih, Onec Birgul, Ayli Deniz, Gonul Ipek Isik, Onec Kursad
Department of Nephrology, Ankara Numune Training and Research Hospital, Ankara, Turkey.
Scand J Urol Nephrol. 2008;42(2):178-80. doi: 10.1080/00365590701571514.
Mycophenolate mofetil (MMF) is considered to be a promising therapeutic agent in primary glomerulonephritis but there are no data on the use of MMF in Henoch-Schönlein nephritis (HSN). Herein we report the first adult crescentic HSN patient in whom long-term complete remission was achieved after MMF therapy.
霉酚酸酯（MMF）被认为是原发性肾小球肾炎中有前景的治疗药物，但尚无关于MMF用于紫癜性肾炎（HSN）的相关数据。在此，我们报告首例成人新月体性HSN患者，其在接受MMF治疗后实现了长期完全缓解。
